Skip to contentB
Boston Scientific Corp
B
BSXBoston Scientific Corp Source filing unavailable
Q2 2015 · —
Revenue$1.98B$1.98B+6.0% vs Q2 2014 Net Income$102.00M$102.00M+2,450.0% vs Q2 2014 EPS Diluted$0.08$0.08— vs Q2 2014 Gross Profit$1,303,000,000−0.5% Operating Income$219,000,000N/M Operating Cash Flowderived
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Boston Scientific Corp · CIK 885725 · Engraved from SEC EDGAR
$60,000,000
−78.9%
Free Cash Flowderived$14,000,000−93.6% Margins · derivedGross margin65.8%−4.3 pt vs Q2 2014
Operating margin11.1%+14.7 pt vs Q2 2014
Net margin5.1%+4.9 pt vs Q2 2014